DATA GRAPHICS | Data Byte
Centerview Partners acted as an adviser to 64% of the biotechs acquired in $1B+ deals
By Gunjan Ohri, Data Content Analyst
January 23, 2024 11:19 PM UTC
Centerview had a busy year in M&A deals in 2023, advising the sellers in more than half of the $1 billion-plus biotech takeouts announced during the year.
Among the 28 acquisitions valued at $1 billion or more last year, Centerview Partners was an adviser to 18 of the acquired companies, with Goldman Sachs & Co. LLC coming in second at six deals. BofA Securities was adviser to four companies, and J.P. Morgan to three. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/651215/centerview-advised-most-of-the-sellers-in-2023-s-largest-m-a-deals